Heart-disease study launched in NS CMAJ 1997;157:127 © 1997 Canadian Medical Association Nova Scotia patients are being enrolled in one of the largest population-based studies undertaken to measure and improve treatment for heart disease. Merck Frosst Canada is spending $6 million to fund the study, which is being undertaken in cooperation with the government and the Cardiology Division of the Queen Elizabeth II Health Sciences Centre in Halifax. The project will enrol several thousand patients hospitalized with heart disease at 10 hospitals, as well as high-risk patients from physicians' practices across the province. The 5-year study will use evidence-based practices to measure all aspects of care and health outcomes for these patients. Send a letter to the editor responding to this article Envoyez une lettre à la rédaction au sujet de cet article | CMAJ July 15, 1997 (vol 157, no 2) / JAMC le 15 juillet 1997 (vol 157, no 2) |